Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer by Lukianova-Hleb, Ekaterina Y. et al.
Theranostics 2011, 1 
 
 
http://www.thno.org 
3 
T Th he er ra an no os st ti ic cs s   
2011; 1:3-17 
Research Paper 
Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer 
Ekaterina Y. Lukianova-Hleb1, Alexander O. Oginsky1,2, Adam P. Samaniego1, Derek L. Shenefelt3, Daniel S. 
Wagner3, Jason H. Hafner4, Mary C. Farach-Carson3, Dmitri O. Lapotko1,3,4    
1.  Joint American-Belarusian Laboratory for Fundamental and Biomedical Nanophotonics, Rice University, 6100 Main 
Street, Houston, TX, 77005, USA;  
2.  Belarusian State University for Informatics and Radioelectronics, 6 Browka Street, Minsk, 220013, Belarus;  
3.  Department of Biochemistry & Cell Biology, Rice University, 6100 Main Street, Houston, TX, 77251-1892, USA;  
4.  Department of Physics & Astronomy, Rice University, 6100 Main Street, Houston, TX 77005, USA  
 Corresponding author: Dmitri O. Lapotko, PhD, Rice University, Physics and Astronomy - MS 61, 6100 Main Street, 
Houston, TX 77005. Tel: 713-348-3708; Fax: 713-348-4150; E-mail: dl5@rice.edu 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Published: 2011.01.10 
Abstract 
Theranostic applications require coupling of diagnosis and therapy, a high degree of specificity 
and adaptability to delivery methods compatible with clinical practice. The tunable physical 
and biological effects of selective targeting and activation of plasmonic nanobubbles (PNB) 
were studied in a heterogeneous biological microenvironment of prostate cancer and stromal 
cells. All cells were targeted with conjugates of gold nanoparticles (NPs) through an anti-
body-receptor-endocytosis-nanocluster mechanism that produced NP clusters. The simul-
taneous pulsed optical activation of intracellular NP clusters at several wavelengths resulted in 
higher optical contrast and therapeutic selectivity of PNBs compared with those of gold NPs 
alone. The developed mechanism was termed “rainbow plasmonic nanobubbles.” The cellular 
effect of rainbow PNBs was tuned in situ in target cells, thus supporting a theranostic algorithm 
of prostate cancer cell detection and follow-up guided destruction without damage to col-
lateral cells. The specificity and tunability of PNBs is promising for theranostic applications and 
we discuss a fiber optic platform that will capitalize on these features to bring theranostic 
tools to the clinic. 
Key  words:  Plasmonic  nanobubble,  gold  nanoparticle,  laser,  photothermal,  prostate  cancer, 
theranostics. 
Introduction 
The  biomedical  applications  of  plasmonic  na-
noparticles (NPs) use their optical scattering proper-
ties for imaging and diagnostics [1-4], and their pho-
tothermal  properties  for  various  types  of  therapies 
through the generation of heat [1,5,6], bubbles [6-12] 
and acoustic waves [13,14]. The specificity and sensi-
tivity of imaging and diagnostics, as well as the selec-
tivity and efficacy of the therapeutic methods, depend 
upon  the  selectivity  of  NP  delivery  and  activation 
within their targets, typically diseased cells or tissues. 
The initial application of various NPs was based on 
passive targeting [15-17], which did not allow the NPs 
to recognize their specific molecular targets and re-
sulted in the low selectivity of NP-based methods and 
also in potentially toxic loads of NPs. The situation 
was  improved  by  using  active  molecular  targeting 
with  cell-specific  molecules  (peptides,  antibodies, 
aptamers) attached to NPs and coupling to cognate 
receptors  at  the  membranes  of  specific  target  cells 
[18-21]. This approach is currently used for the in vitro Theranostics 2011, 1 
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and  in vivo  application  of  NP-based  imaging,  diag-
nostics  and  therapies  including  drug  delivery  with 
gold NPs [22-26] and, ultimately, for theranostics, the 
method  that  unites  diagnosis  and  therapy  in  one 
procedure [27-33].  
However,  NP  conjugates  still  do  not  provide 
“absolute”  targeting:  certain  amounts  of  NPs  miss 
their  targets  and  are  taken  up  nonspecifically  by 
neighboring  cells  and  tissues.  Consequently,  the 
specificity and sensitivity of imaging and diagnostics, 
and  the  selectivity  and  efficacy  of  the  therapeutic 
methods, are reduced. On the other hand, the major 
promise of NP-based medicine is associated with the 
unique properties of NPs and the nanoscale processes 
they support. To realize this promise, one needs tar-
geting and activating mechanisms that provide selec-
tive delivery and activation of the NPs only in target 
cells  without  influencing  other  normal  cells.  Other-
wise NP-based medicine (often referred to as nano-
medicine)  often  defaults  to  its  “macro”  version  by 
employing only the bulk "macro" effects of NPs, and 
thus losing their main advantage over macro- materi-
als and methods. 
To  address  these  problems,  we  recently  intro-
duced the antibody-endocytosis based mechanism of 
gold NP targeting and activation [34-36]. This mech-
anism works through the selective formation of NP 
clusters  (tightly  aggregated  groups  of  5-50  NPs)  in 
specifically  targeted  cells  and  the  cluster 
size-dependent  mechanism  of  optical  activation  of 
such NP clusters through the generation of plasmonic 
nanobubbles (PNBs) [35-38]. Endocytosis provides the 
selective formation of big NP clusters only in diagno-
sis-specific cells, while fewer NPs incidentally accu-
mulated by non-specific cells are insufficient to form 
an NP cluster. PNBs are generated as transient vapor 
bubbles around intracellular NP clusters under their 
exposure to short laser pulses. Unlike other thermal, 
acoustical  and  optical  phenomena  related  to  plas-
monic  NPs,  the  generation  of  PNBs  is  a  threshold 
process: a PNB does not emerge if the laser pulse en-
ergy is below a specific threshold. The PNB threshold 
energy significantly depends upon the NP cluster size 
[37-39], thus allowing the selective generation of PNBs 
only  around  big  enough  clusters  (the  lowest  PNB 
threshold) that cannot be formed in non-specific cells. 
The dynamically tunable optical (i.e. diagnostic) and 
mechanical (i.e. therapeutic) properties of PNBs make 
them ideal candidates for cell-level imaging, diagnos-
tics, therapy and, ultimately, theranostics [34,38,40].  
However, a general heterogeneity of biological 
properties  (including  the  expression  of  specific  re-
ceptors and their ability to support endocytosis) often 
reduces the selectivity of NP targeting and the preci-
sion of the following diagnosis and therapy [21,41-43]. 
As a result, NP-based biomedical technologies often 
cannot provide cell-level diagnosis and therapy. The 
other significant limitation of various nanoprobes is 
the limited (or nonexistent) tunability of their function 
in a cell. We hypothesized that a further improvement 
in the selectivity and tunability of NP-based imaging, 
diagnosis, and therapy, and the unification of these 
steps  into  one  theranostic  procedure  could  be 
achieved with the simultaneous activation of the sev-
eral different and co-locolized plasmon resonances in 
one NP cluster, and through the generation of tunable 
localized PNBs. Our current work is focused on the 
experimental  evaluation  of  this  hypothesis  for  gold 
NPs and associated PNBs. Below we report the ex-
perimental results for a new selective mechanism of 
PNB generation around clusters of gold NPs, and the 
evaluation of the developed mechanism at cell level 
for the theranostics of prostate cancer cells growing 
amidst normal stroma. 
 
Methods 
Generation of rainbow plasmonic nanobubbles 
The  generation  of  a  vapor  bubble  around  a 
plasmonic NP (Figure 1A) requires a specific thresh-
old of the fluence of the laser pulse. When the thresh-
old is exceeded, the optical energy is converted in the 
NP by the mechanism of plasmon resonance into a 
sufficient  amount  of  thermal  energy  that  is  rapidly 
transferred to the NP nano-environment, evaporates 
this nano-environment, and provides the expansion of 
the  vapor  into  the  nanobubble.  The  clustering  of 
plasmonic NPs was shown to reduce the PNB gener-
ation threshold [37,38].  
The described mechanism employs one plasmon 
resonance  as  the  source  of  heat.  We  expanded  this 
approach into a principally new mechanism that em-
ploys  the  simultaneous  effect  of  several  different 
plasmon resonances in one NP cluster. This was real-
ized through using two different types of plasmonic 
(gold)  NPs,  rods  and  spheres,  and  their  clustering 
through  collective  endocytosis  (Figure  1B).  If  this 
multi-NP cluster is irradiated with one laser pulse at 
sub-threshold fluence (below the PNB threshold for 
clusters of a similar size though built of only one type 
of NP) there will be no bubble (Figure 1C). However, 
if we irradiate this multi-NP cluster with two simul-
taneous pulses at two different wavelengths (match-
ing the plasmon resonances of the NPs), their cumu-
lative  thermal  effect  will  exceed  the  PNB  threshold 
and will result in a PNB (Figure 1C).  Theranostics 2011, 1 
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Figure 1. Principle of optical generation and detection of (A) standard PNB generated with single laser pulse around 
mono-NP cluster and (B) rainbow PNB generated with several laser pulses (shown with green and purple arrows) and 
multi-NP cluster (yellow and purple NPs with different plasmon resonances), (C) thermal outputs of single NPs, mono-NP 
clusters and multi-NP clusters under identical optical excitation with two laser pulses (as in case (B)): only the synergistic 
effect of two simultaneous plasmon resonances in one NP cluster deliver the thermal energy sufficient for PNB generation. 
Red arrows in (A) and (B) show PNB detection through optical scattering of an additional probe laser beam. 
 
This  new, “rainbow” mechanism is principally 
different from the standard one in the following ways: 
1. A single source of optical energy (a laser pulse 
at a single wavelength) is replaced by several sources 
(several  pulses  of  different  wavelengths),  while  the 
fluence of each pulse is reduced below the PNB gen-
eration threshold for each corresponding NP type. In 
such  cases,  the  simultaneous  exposure  of  the 
mono-NP cluster or the single pulse exposure of the 
mono- or multi-NP cluster will not generate a PNB, 
because the thermal output in both cases will be in-
sufficient, and only the simultaneous excitation of the 
multi-NP cluster will cause the bubble.  
2. A reduced fluence of laser pulses results in a 
reduced  initial  temperature  of  individual  corre-
sponding  NPs  compared  with  the  case  of  a  single 
pulse excitation. The simultaneous heating of closely 
packed  different  NPs  results  in  a  rapid  fusion  (su-
perposition)  of  their  thermal  fields  into  one  joint 
thermal field surrounding the NP cluster. This ther-
mal field acts as the energy source for the vapor bub-
ble formation and expansion, and, compared with the 
single plasmon resonance case, the thermal load on 
the NPs is reduced, thus better protecting them from 
melting and enabling multiple activations. 
3. The independent control of the fluence of each 
laser pulse allows us to optimize the excitation of the 
multi-NP cluster for maximal selectivity of PNB gen-
eration, whereas excitation with a single pulse does 
not offer this opportunity. 
From  the  biomedical  point  of  view  the  above 
features can be considered as a reduction of the radi-
ation load on a tissue and an improvement in PNB 
selectivity in a heterogeneous cell environment when 
different NPs are targeted with the different vectors 
(antibodies, peptides etc). Optical generation and de-
tection of the PNBs was performed with a previously 
developed  photothermal  laser  microscope  [44] 
equipped with a dual pulsed laser (STH-01, Standa 
Ltd, Vilnius, Lithuania): each pulse 0.5 ns, the wave-
length  of  532  nm  (matching  plasmon  resonances  of 
gold  spheres  of  60  nm)  and  tunable  near-infrared 
(matching plasmon resonances of gold nanorods and 
nanoshells that were employed). Three types of gold 
NPs were used to form the multi-NP clusters: gold 
spheres (50 and 60 nm), rods (25x75 nm) and shells (52 
nm).  
The  optical  detection  of  PNBs  was  realized  in 
two parallel modes: time-resolved scattering imaging 
(Figure 2A, C, E) and time response (Figure 2B, D, F). 
Time-resolved  scattering  imaging  was  realized  by 
using side illumination of the sample with a pulsed 
probe laser beam at a wavelength of 690 nm, different 
from the pump laser wavelengths (of 532 nm, 787 nm 
and 675 nm). Optical scattering was also used for the 
imaging of single NPs and their clusters. For objects 
whose dimensions are smaller than a wavelength, the 
size of their image does not represent their actual size. 
However, if the image is formed by the light scattered 
by  the  object,  the  brightness  of  the  scattered  light 
(measured as the pixel image amplitude) correlates to 
the size of the object. We used this well-known rule 
for the quantitative control of the relative size of the 
gold nanoparticle clusters. This provided a compari-
son of the clusters of similar size. The probe laser ra-
diation scattered by NP or by PNB was imaged with a Theranostics 2011, 1 
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CCD  camera  (Luka,  Andor  Technologies,  Ireland). 
While  allowing  us  to  “see”  the  PNB  or  NP,  a 
time-resolved  scattering  imaging  cannot  provide  a 
kinetic measurement. The latter was realized with a 
simultaneous time response mode [44]. An additional 
continuous  probing  beam  (633  nm)  was  directed  at 
the sample and focused on it collinearly with pump 
laser beams, and its axial intensity was monitored by 
a  high-speed  photodetector  (PDA110AC,  Thorlabs 
Inc.) and a 400-MHz Lecroy digital oscilloscope. The 
PNB-induced scattering of a part of the probe beam 
decreased  its  axial  amplitude,  resulting  in  a 
dip-shaped  output  signal  [44].  This  mode  provided 
the monitoring of PNB growth and collapse, and de-
livered the PNB lifetime that characterizes its maximal 
diameter [44]. The PNBs were quantified by measur-
ing their lifetime, bubble generation threshold fluence 
and  the  pixel  amplitude  of  their  scattering  images. 
The PNB generation threshold fluence of the pump 
laser pulse describes both the efficacy of the photo-
thermal  conversion  by  NPs  and  the  hydrodynamic 
conditions of PNB generation. The laser fluence that 
provides PNBs generation probability 0.5 was defined 
as pump laser pulse fluence. 
Results and Discussion 
Mechanism of rainbow plasmonic nanobubbles 
Initially  we  studied  the  generation  of  PNBs 
around  mono-NP  and  multi-NP  clusters  in  water. 
Optical  detection  of  the  PNBs  was  realized  in  two 
parallel  modes:  time-resolved  scattering  imaging 
showed individual transient PNBs at the moment of 
their generation and delivered the information about 
the brightness of PNBs (Figure 2A, C, E), and time 
response  mode  employed  a  continuous  probe  laser 
(633 nm) to monitor the PNB growth and collapse and 
thus to obtain the PNB lifetime that characterizes the 
maximal diameter of the PNB [44] (Figure 2B, D, F). 
We  studied  several  combinations  of  NPs  and  their 
optical  excitation  in  order  to  compare  the  single 
wavelengths excitation of one type of NPs with the 
multi-wavelength  excitation  of  the  mixed  types  of 
NPs (Table 1). For each condition, we measured the 
lifetime  of  individual  PNBs  that  were  generated 
around individual NP clusters under a single pulse 
excitation. 
Under identical excitation conditions (532 nm: 6 
mJ/cm2, 787 nm 14 mJ/cm2) the clusters of spheres 
(Table 1, Figure 2A, B) and rods (Table 1, Figure 2C, 
D)  returned  no  or  small  PNBs,  while  the  multi-NP 
clusters  of  the  same  size  returned  relatively  large 
PNBs (Table 1, Figure 2E, F) that were associated with 
apparently  over-threshold  conditions.  Both  fluence 
levels were chosen to be significantly below the PNB 
generation thresholds for single NPs (46 mJ/cm2@532 
nm  for  NSP  and  32  mJ/cm2@787  nm  for  NRs)  and 
slightly below the PNB generation thresholds for the 
mono-NP clusters of NSPs (16 mJ/cm2@532 nm) and 
NRs (20 mJ/cm2@787 nm), in order to compare the 
standard  and  rainbow  mechanisms  of  PNB  genera-
tion.  
 
Figure  2. A,C,E: time-resolved scattering optical images 
show individual transient PNBs generated around single NP 
clusters  during  exposure  to  the  two  simultaneous  laser 
pulses (0.5 ns each, 532 nm and 787 nm): A - the mono-NP 
cluster of gold spheres, C - the mono-NP cluster of gold 
rods, E - the multi-NP cluster of the same diameter as in A 
and C but consisting of a mixture of gold spheres and rods; 
the pixel image amplitude is shown in the gray scale. B, D, F: 
corresponding  time  responses  obtained  simultaneously 
with the images A,C,E and characterize maximal diameter of 
the PNB through the duration of the PNB-specific signal. 
Scale bar is 10μm. 
 
Similar results were obtained for the clusters of 
two  different  hollow  gold  nanoshells  with  the  ab-
sorbance peaks at 575 nm and 690 nm (Table 1). We 
applied 532 nm@10 mJ/cm2 pulses and 675 nm@10 
mJ/cm2 pulses separately and simultaneously. Single 
pulse excitation of the mono-NS clusters returned no 
or small PNBs. Maximal lifetime and probability of 
PNBs  were  obtained  under  dual  excitation  of  the 
mixed  NS  clusters  that  included  both  types  of  NS Theranostics 2011, 1 
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(Table 1). This lifetime, 133 ns, was 2-3 times longer 
(indicating a two to three fold bigger diameter of the 
PNB)  compared  with  the  dual  excitation  of  the  NS 
clusters of a similar size but consisting of one type of 
NS.  
Table 1. PNB lifetime (ns) (measure of its maximal diam-
eter) obtained for individual gold NP clusters of similar size 
for the different combinations of NP types and the wave-
lengths of optical excitation (@optical fluence, mJ/cm
2). 
NP cluster composi-
tion 
Spheres 
(532 
nm) 
Rods 
(750 
nm) 
Spheres 
+rods 
Shells 
(560 
nm) 
Shells 
(690 
nm) 
Shells 
+ 
shells 
Optical absorbance 
peak, nm 
532  800    560  690   
Laser pulse wave-
length, nm 
           
532 @10 mJ/cm2  0  0  0  0  0  46±7 
675@10 mJ/cm2  0  -  -  14±3  26±4  40±5 
787@14mJ/cm2)  0  0  15±2  -  -  - 
532(6 mJ/cm2)+787(14 
mJ/cm2) 
10±3  14±3  63±4  -  -  - 
532+675@10 mJ/cm2 
for both pulses 
58±5  -  -  47±3  72±5  133±13 
 
The  size  of  NP  clusters  was  quantified  and 
compared  through  the  amplitudes  of  their  optical 
scattering  images  (obtained  for  individual  NP  clus-
ters).  We  studied  the  clusters  that  yielded  similar 
scattering image amplitudes for all three cluster types. 
In addition, the composition and dimensions of the 
clusters were verified with scanning electron micros-
copy (SEM, Figure 3). We used 60 nm spheres (NSP), 
25x75  nm  nanorods  (NR)  and  multi-NP  (NSP-NR) 
clusters  consisting  of  spheres  and  rods  (Figure  3). 
According  to  their  SEM  images,  the  size  of  these 
clusters was 130-180 nm. Figure 3C clearly shows the 
multi-NP  nature  of  the  clusters  that  delivered  the 
images and signals shown in Figure 2E, F. 
The therapeutic effect of PNBs is associated with 
their  mechanical  impact  [34,37,40,45]  that  is  charac-
terized  by  the  maximal  diameter  of  the  expanding 
PNB and is measured through the lifetime of the PNB 
(Figure 4). The diagnostic effect of a PNB is associated 
with its brightness that is characterized through the 
pixel image amplitudes (Figure 2A,C,E), normalized 
by the pixel image amplitudes of the corresponding 
NP clusters as measured prior to their optical excita-
tion  and  calculated  as  an  amplification  of  optical 
scattering by the PNB relative to that by the NP clus-
ter (Figure 4). The results obtained (Table 1, Figures 2, 
4) show the definite priority of the novel “rainbow” 
mechanism  over  the  standard  excitation  of  a  single 
plasmon  resonance:  the  lifetime  and  brightness  of 
rainbow  PNBs  increased  by  almost  one  order  of 
magnitude compared with the identical excitation of 
the mono-NP clusters.  
 
 
Figure 3. SEM images of the clusters prepared from: (A) gold solid spheres (NSP) 60 nm, (B) gold rods (NR) 25x75 nm, (C) 
gold NRs and NSPs (multi-NP cluster). 
 
 
Figure 4. Lifetime and brightness (relative to that of the 
corresponding  NPs)  of  individual  PNBs  generated  in 
water with two simultaneous laser pulses (0.5 ns, 532 
nm@6 mJ/cm
2 and 787 nm@14 mJ/cm
2): around single 
NPs, spheres (plasmon peak close to 532 nm) and na-
norods  (plasmon  peak  close  to  787  nm);  around 
mono-NP clusters consisting of spheres (NSP) or rods 
(NR) and around multi-NP clusters that included both 
NSP and NR (rainbow mechanism).  
 Theranostics 2011, 1 
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To  compare  the  efficacy  of  the  rainbow  and 
standard mechanisms, we determined the fluence of 
the single laser pulse that provided the same lifetime 
of  the  PNB  around  a  mono-NP  cluster  as  was 
achieved  for  the  rainbow  PNB.  The  PNB  lifetimes 
close to those of the rainbow PNBs required the fol-
lowing fluences of the single 532 nm laser pulse: 
  for  NSP  cluster  -  3-4  fold  (48  mJ/cm2  vs.  14 
mJ/cm2 in rainbow mode); 
  for  NS  cluster  -  2-3  fold  (27  mJ/cm2  vs.  10 
mJ/cm2 in rainbow mode).  
Therefore,  the  simultaneous  dual  pulse  excita-
tion of the mixed NP cluster pulses resulted in a sig-
nificant  increase  in  the  PNB  generation  probability 
and lifetime for all combinations of gold NPs tested. 
Thus the rainbow PNB mechanism provides an op-
portunity for improving the selectivity and efficacy of 
the generation of rainbow PNBs in biomedical appli-
cations. Another interesting opportunity is related to 
the tunability of PNB size (which is the measure of its 
therapeutic and diagnostic effect). According to Table 
1 and Figure 4 the single pulse excitation delivered 
PNBs with a lifetime below 100 ns, the threshold that 
was  earlier  found  by  us  to  separate  non-invasive 
PNBs from ablative ones [34,40]. However, the dual 
pulse excitation mode returned PNBs with a lifetime 
above 100 ns, that can be considered as ablative for 
cells. Therefore, varying the number of the pump laser 
pulses  we  can  support  and  switch  between  the 
non-invasive  diagnostic  and  ablative  therapeutic 
modes. This option was studied in detail below.  
Rainbow plasmonic nanobubbles in living cells  
The internalization and clustering of NPs in liv-
ing cells (unlike the water model studied above), in-
volves several biological processes that not only form 
such clusters, but also create significant heterogeneity 
in their size. The latter factor determines the specific-
ity of NP- and PNB-based diagnosis and the efficacy 
and selectivity of the NP- and PNB-based therapy. We 
studied  NP  clustering  and  PNB  generation  in  a 
co-culture  of  living  bone  metastatic  prostate  cancer 
(C4-2B) and human bone marrow stromal (HS-5) cells 
in vitro under the following conditions:  
1. The initial targeting of the cells with gold NPs 
was  supported  by  using  a  combination  of  the  two 
different antibodies that were conjugated to specific 
different  gold  NPs.  We  applied  prostate  can-
cer-specific  gold  conjugates  of  NSP  with  PSMA 
(prostate  specific  membrane  antigen)  and  gold  NS 
conjugated  with  C225  (Erbitux,  the  antibody  raised 
against  human  EGF  receptor)  that  is  tu-
mor-associated, although it is less specific to prostate 
cancer cells than PSMA. The rods were replaced by 
other  NPs  with  NIR  plasmon  resonances,  by 
nanoshells (NS), because the latter turned out to be 
less toxic and easier to conjugate. The specificity and 
efficacy of PSMA-based targeting was independently 
verified  with  fluorescent  confocal  microscopy 
(LSM-710, Zeiss) of C4-2B and HS-5 cells that were 
identically treated with the conjugate of fluorescent 
dye with PSMA, AlexaFluor488-PSMA (Figure 5A,D). 
This step did not provide absolute specificity of the 
targeting and, therefore, we applied the next targeting 
step. 
2. The clustering of the membrane-accumulated 
NPs  was  provided  by  their  endocytosis  and  subse-
quent aggregation in endosomal compartments in the 
cytoplasm. This process was monitored in C4-2B and 
HS-5 cells that were incubated with gold NPs by us-
ing  the  reflecting  mode  of  the  confocal  microscope 
with  a  633  nm  laser  (Figure  5B,E).  The  size  of  NP 
clusters  was  analyzed  through  the  image  pixel  am-
plitude of the scattering images of the NP clusters in 
cells. According to this metrics, the C4-2B cells formed 
much bigger clusters of NPs than those in HS-5 cells 
(Figure 5B,C,E,F). 
Next we studied the process of the generation of 
PNBs in individual cells. Living cells were individu-
ally exposed to single laser pulses of a specific wave-
length and fluence and to pairs of laser pulses. PNBs 
were detected and quantified through their responses 
and  time-resolved  scattering  images.  Thus  we  ob-
tained the probability of PNB generation, lifetime and 
scattering image amplitude. Firstly, each cell was ex-
posed  to  laser  pulses  at  532  nm@16  mJ/cm2,  787 
nm@19 mJ/cm2 and to the simultaneous pair of these 
pulses.  The  PNB  lifetimes  and  the  probabilities  of 
their generation were plotted as shown in the diagram 
(Figure 6A).  
The rainbow mechanism (which mixed targeting 
the cells with NS-C225 and NSP-PSMA and exposing 
them  to the two simultaneous laser pulses, 532 nm 
and 787 nm) resulted in an increase in PNB size (life-
time)  of  almost  one  order  of  magnitude  compared 
with  the  response  of  the  same  cells  to  mono-pulse 
treatments (Table 2). This result confirmed our pre-
vious findings (obtained for the water model), that the 
efficacy of rainbow PNB generation was much higher 
than for standard PNBs. In addition to the improved 
efficacy (increased lifetime of the rainbow PNB), we 
observed  the  better  selectivity  (C4-2B  versus  HS-5 
cells)  of  the  rainbow  PNBs  compared  with  the 
mono-pulse generated PNBs in the same cells (Figure 
6A). Next, we increased the fluence of 532 nm to the 
level that provided the lifetime of a PNB close to that 
achieved in the rainbow mode (95 ns). This required 
increasing the fluence of the 532 nm laser pulse to 86 Theranostics 2011, 1 
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mJ/cm2. This fluence level exceeded the summarized 
fluence of the two laser pulses (16+19=35 mJ/cm2) by 
2.5 times. Such a difference in the fluences indicates 
that the simultaneous activation of several plasmon 
resonances in multi-NP clusters resulted in the syn-
ergistic effect of the co-localized excitation of several 
plasmon resonances in spheres (532 nm) and in shells 
(787 nm).  
 
Figure 5. Confocal fluorescent, confocal scattering images of prostate cancer C4-2B (A,B) and stromal HS-5 (D,E) cells: 
(A,D) - confocal fluorescent images of AlexaFluor488 conjugated to PSMA antibody, (B,E) - confocal scattering images of 
gold NPs clusters (shown in red on the green fluorescent background that shows cell tracker dye) and (C,F) the corre-
sponding profiles of scattering signal amplitudes by gold NPs clusters in cells. 
 
 
 
Figure 6. PNB lifetime-probability of generation diagrams obtained for the cell samples. A - prostate cancer (C4-2B) and 
stromal (HS-5) cells that were treated with the mixture of gold NP conjugates (NSP60-PSMA and NS110-C225) and were 
exposed to single and paired laser pulses (532 nm@16 mJ/cm
2 and 787 nm@19 mJ/cm
2): for C4-2B cells: hollow star – single 
pulse 532 nm, half right star – single pulse 787 nm, solid star – pair of laser pulses at 532 nm and 787 nm (rainbow 
mechanism); for HS-5: hollow circle – single pulse 532 nm, half right circle – single pulse 787 nm, solid circle – pair of laser 
pulses at 532 nm and 787 nm (rainbow mechanism). B – prostate cancer cells (C4-2B) that were treated with hollow gold 
shells 52 nm and were exposed to single and paired laser pulses (532 nm@10 mJ/cm
2 and 675 nm@8 mJ/cm
2): half right 
square – single pulse 532 nm, hollow square – single 675 nm pulse, solid square - pair of laser pulses at 532 nm and 675 nm. 
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Table 2. C4-2B cell population averaged PNB lifetimes (ns) under various NP targeting and laser excitation conditions 
(wavelength, nm /fluence, mJ/cm
2). 
NPs  
(antibody/diameter/plasmon resonance peak) 
NS 
(C225/52nm/690 nm) 
NSP+NS 
(C225/110nm/800) 
532 nm, 10 mJ/cm2  1.8±2  - 
675 nm, 8 mJ/cm2  1.0±1  - 
532 nm (10 mJ/cm2)+675 nm (8 mJ/cm2)  105.0±13  - 
532 nm, 16 mJ/cm2  -  12.0±3 
787 nm, 19 mJ/cm2  -  3.2±1 
532 nm (16 mJ/cm2)+787 nm (19 mJ/cm2)   -  72.0±4 
 
 
The advantage of gold NSs over gold NSPs of the 
same diameter for the generation of PNBs was dis-
covered and discussed earlier in terms of the physical 
mechanism  of  PNB  generation  [38].  Based  on  the 
above,  we  additionally  studied  different  excitation 
modes for PNB generation in C4-2B cells treated with 
the NS52-C225 conjugates (plasmon peak around 690 
nm)  and  applied  a  single  pulse  (532  nm)  and  dual 
pulse (532 nm and 675 nm) optical excitation under 
identical  fluences.  In  this  case  we  intentionally  ap-
plied the fluences of each pulse at the level below the 
PNB  generation  threshold  for  a  single-pulse  mode, 
532 nm, 10 mJ/cm2 and 675 nm, 8 mJ/cm2. Almost no 
PNBs  were  generated  in  cells  in  single-pulse  mode 
(Figure 6B, Table 2). However, the dual-pulse mode 
returned PNBs with a lifetime above 100 ns. This was 
achieved  without  increasing  the  fluence  of  laser 
pulses  (that  was,  in  this  case,  within  the 
FDA-approved  safe  limit,  20  mJ/cm2  [46])  and 
through the rainbow mechanism of PNB generation. 
To  achieve  a  similar  PNB  lifetime  in  single  pulse 
mode in the same cells, we had to increase the fluence 
of the 532 nm pulse to 27 mJ/cm2, a level higher than 
the summarized fluence of 532 nm and 675 nm pulses 
(18 mJ/cm2) and also higher than the FDA-approved 
safety limit. The obtained lifetimes of PNBs (Table 2, 
Figure 6B) indicated a significant difference between 
the single pulse and dual pulse (rainbow) excitation 
modes.  Again,  like  in  the  previous  experiment,  the 
lifetime of the rainbow PNBs was one to two orders of 
magnitude higher than the lifetimes of PNBs under a 
single  pulse  excitation.  The  latter  were  mainly  not 
generated at all under the reduced level of laser flu-
ences. 
These experiments clearly demonstrate that the 
rainbow  mechanism  of  PNB  generation  (i.e.  du-
al-pulse optical excitation of PNBs) improves the se-
lectivity of PNB generation and also reduces the laser 
fluence  required  to  generate  PNBs  to  the  minimal 
level. Our next step was to study in detail the poten-
tial of rainbow PNBs for diagnostic and therapeutic 
applications for the same cell model of prostate cancer 
cells growing amongst normal stromal cells. 
Diagnostic properties of plasmonic nanobubbles.  
The  diagnostic  specificity  and  sensitivity  of 
PNBs  were  evaluated  by  comparing  the  brightness 
and optical contrast of rainbow PNBs with those of 
gold  NPs  (scattering)  and  AlexaFluor488  label 
(PSMA-specific fluorescence) (Figure 7). We applied 
the  reduced  fluence  (532  nm@10  mJ/cm2  and  787 
nm@12 mJ/cm2) in order to generate relatively small, 
non-invasive PNBs with a lifetime below 100 ns (that 
had  previously  been  found  to  be  the  threshold  for 
transition  from  non-invasive  to  ablative  bubbles 
[34,40]).  The  viability  of  each  individual  cell  was 
monitored by measuring the level of fluorescence of 
specific vital dyes that leak out from the damaged cell 
(PNB-induced cell damage was shown to have a dis-
ruptive mechanical nature [40,45,47]).  
We  fluorescently  labeled  stromal  (HS-5)  and 
prostate cancer cells (C4-2B) with calcein vital dyes of 
red  (cancer)  and  green  (stromal)  colors  and  mixed 
them in the proportion HS-5:C4-2B of 5:1 (Figure 8A). 
The  brightness  of  the  PNBs  in  cancer  C4-2B  cells 
(measured as the pixel image amplitude of the PNB, 
Figure 7F) was found to be 71 times higher than that 
for stromal cells (Figure 7H). Such an optical contrast 
exceeded the optical contrast of the fluorescent labels 
(that were targeted to C4-2B and HS-5 cells using the 
same  prostate  cancer-specific  PSMA  antibody,  see 
Figure  7B,  D)  by  31  times.  The  optical  contrast 
(measured as a ratio of the fluorescent image ampli-
tudes for C4-2B to HS-5) of fluorescent imaging for 
cancer  versus  stromal  cells  was  2.3  (Figure  7B,  D). 
Such a high contrast of PNB imaging was achieved 
due  to  their  threshold  mechanism:  no  PNBs  were 
generated in HS-5 cells (Figure 7H), and their images 
were  formed  by  the  optical  scattering  by  gold  NPs 
that did not produce PNBs.  
The above results were achieved with a single 
exposure of each cell to the pair of pump laser pulses. 
As can be seen from Figure 8B, the PNBs did not cause 
detectible changes in the level of Calcein AM fluores-
cence. Therefore, this diagnostic stage of PNB treat-
ment can be considered as non-invasive for all cells 
being treated - target prostate cancer C4-2B cells and 
non-specific stromal HS-5 cells. Theranostics 2011, 1 
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Figure 7. Microscopy images of living cells: bright field (A,C,E,G), time-resolved optical scattering (F,H) and fluorescent 
(Alexa Fluor 488 conjugated to PSMA antibody, B,D) images of prostate cancer C4-2B (A,B,E,F) and stromal HS-5 (C,D,G,H) 
cells; (F) and (H) – time-resolved scattering images of the cells presented in (E) and (G), respectively, that were exposed to 
the pair of laser pulses at 532 nm and 787 nm: image (F) shows the rainbow PNBs in a C4-2B cell while the image (H) shows 
no PNB and only the scattering by residual gold NPs in HS-5 cell. 
 
Figure 8. Fluorescent images of the mixture of prostate cancer C4-2B (red) and stromal HS-5 (green) cells: (A) before, (B) 
after the first scan and (C) 60 s after the second scan, exposure to the pair of laser pulses (532 nm and 787 nm) that se-
lectively generated cell damaging PNBs causing fading of red fluorescence due to leaking of red calcein out through the 
disrupted membrane. Dashed line shows the area that was exposed to the laser pulses. D – cell population averaged flu-
orescent signal amplitudes for C4-2B and HS-5 cells before and after treatment with laser pulses. E and F – the time re-
sponses of PNBs in C4-2B cell obtained during the first and the second scans.  
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Therapeutic properties of plasmonic nanobubbles.  
The  next,  therapeutic,  stage  of  PNB  treatment 
was realized by increasing the energy of the pump 
laser pulses to the level that provided the PNB life-
time well above cell damage level (i.e. longer than 100 
ns). We evaluated the rainbow PNBs for the selective 
ablation  of  cancer  cells  surrounded  by  non-cancer 
stromal cells (a typical cancer microenvironment de-
scribed  above  for  the  diagnostic  stage).  Next,  we 
treated the mixture of cells with the two gold conju-
gates and with two laser pulses, 532 nm@16 mJ/cm2 
and  787  nm@19  mJ/cm2.  The  sample  was  scanned 
through the laser beam and each cell was identified 
according  to  its  fluorescence  (Figure  8B),  and  was 
then exposed to a single pair of laser pulses (Figure 
8C). Based upon the PNB generation probabilities and 
lifetimes (Figure 6), the stable PNBs were generated 
under  the  rainbow  mechanism  and  in  cancer  cells 
only. PNBs were also observed on occasion in stromal 
cells, but their probability was below 20%, and their 
size  was  small  compared  to  the  size  of  cancer-cell 
generated PNBs. This latter result inspired an addi-
tional  test:  because  cell  damage  by  a  PNB depends 
upon its size (lifetime [34,40,44]), we monitored and 
compared the vital fluorescence of PNB treated can-
cerous and stromal cells.  
Within  the  area  irradiated  with  laser  pulses 
(shown within a dashed line in Figure 8B,C) we dis-
covered that only the cancer cell was damaged. The 
vital dye stays in the cell with an intact membrane and 
quickly  leaks  out  of  the  cell  with  a  compromised 
membrane [48]. The damage (ablation) of the cancer 
cell in the center (observed as the loss of the red fluo-
rescence) was in line with the increased size (lifetime) 
of the PNBs generated specifically in C4-2B cells, and 
with the mechanical nature of cell damage that is as-
sociated with the disruption of the cellular structures 
including  the  plasma  membrane  [34,40,44,45,49,50]. 
This final test clearly demonstrates the selectivity of 
the  rainbow  PNBs  that  were  generated  locally  in  a 
single specific (cancer) cell and were not generated in 
the surrounding stromal cells (or were generated in 
such cells with a probability and size that prevented 
their damage). While the vital fluorescent images in 
Figure  8B,C  demonstrate  the  potential  of  rainbow 
PNBs for selective therapy, the optical scattering of 
these PNBs has a high diagnostic potential.  
The  destruction  of  the  cells  was  a  result  of  a 
"single  pulse"  procedure  (the  pair  of  simultaneous 
pulses)  and  was  associated  with  the  mechanical, 
non-thermal  disruption  of  cellular  membrane  and 
other  components.  A  discussion  of  the  cell  damage 
mechanism due to PNBs can be found in our previous 
work  [34,40].  Here  we  would  like  to  point  out  the 
difference in the optical parameters of ablative (de-
structive) and non-invasive (diagnostic) PNBs: their 
lifetimes and optical brightness (measured as the im-
age pixel amplitude) differ significantly (Figure 4,7). 
Long lifetimes of PNBs correlate with the damage to 
prostate cancer cells. Therefore, this optical parameter 
of PNBs can be used as a real-time guidance of the 
PNB effect on a specific cell, in particular, to confirm 
the cell damage that has occurred. 
Rainbow plasmonic nanobubbles as theranostic probes 
The  described  in  vitro  experiments  with  the 
co-culture  of  prostate  cancer  and  stromal  cells 
demonstrate three functions of PNBs: diagnosis, abla-
tive therapy and real-time guidance. Providing that 
each stage is supported by a single exposure to a short 
pulse laser radiation (in a sub-nanosecond range) and 
the  typical  time  of  the  PNB  signals  is  in  a 
sub-microsecond range, there is a direct possibility to 
unite these three vital steps of diagnosis, therapy and 
therapy confirmation (guidance) into one connected 
theranostic procedure. Next, the developed rainbow 
mechanism has demonstrated a single cell specificity 
and  selectivity,  which  was  not  previously  achieved 
with other NP-based methods. Plasmonic NPs alone 
were widely employed for imaging through  optical 
scattering  [1-4],  which  demonstrated  good  in  vitro 
results. The problems of NP scattering imaging begin 
when the background scattering of non-specific cells 
and tissues dominates the NP signals, a common in 
vivo case. An increase in the sensitivity of scattering 
imaging  can  be  achieved  through  generating  PNBs 
around NPs, as we demonstrate above, because the 
scattering of such vapor nanobubbles is brighter than 
that of gold NPs [37,38,47,51]. In addition to higher 
brightness, the threshold mechanism of PNB genera-
tion (unlike the non-threshold mechanism of optical 
scattering and fluorescence) further improves the op-
tical contrast of gold NPs. The rainbow PNB method 
further  develops  the  unique  properties  of  PNBs 
though  the  multi-resonance  mechanism.  There  are 
several  mechanisms  for  the  optical  activation  of 
plasmonic  NPs.  Excitation,  the  most  common,  em-
ploys  continuous  radiation  [52-54],  which  is  a  rela-
tively  simple  and  low  cost  solution.  However,  the 
continuous delivery of optical energy to an NP com-
promises  the  efficacy  and  spatial  selectivity  of  the 
photothermal output of such an NP due to thermal 
diffusion [55]. This problem was solved by using short 
laser pulses [11,12,56-58]. Very short (fs) single pulses 
improve  the  photothermal  efficacy  by  minimizing 
heat loss by NPs, though at the same time they limit 
the efficacy of PT conversion, since maximal energy is Theranostics 2011, 1 
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limited by the optical breakdown threshold. For this 
reason, many fs-pulsed lasers are used in continuous 
mode  [26,59].  Other  than  as  thermal  sources,  plas-
monic  NPs  are  employed  as  sources  for  acoustic, 
shock  waves  and  vapor  bubbles.  Among  these 
mechanisms,  the  gold  nanoparticle-generated  vapor 
bubbles (PNBs) were shown to provide the best selec-
tivity and accuracy for cell-level biomedical applica-
tions.  
Using  the  data  for  NSP  clusters,  we  estimated 
fluences of a single 532 nm pulse required to generate 
the "standard" PNBs with a lifetime close to those of 
the  rainbow  PNBs  as  in  the  experiments  reported 
above. Such a “projected fluence” of a single 532 nm 
pulse was found to be higher that the sum of the flu-
ences  of  the  two  pulses  (532  nm  and  787  nm)  em-
ployed  for  the  excitation  of  the  rainbow  PNB.  This 
difference  increased  with  the  fluence  and  PNB  life-
time from 1.5 to 4. This means that the mechanism of 
the excitation of rainbow PNBs has a synergetic na-
ture. Compared to a “standard” mechanism of nano-
bubble generation around a gold NP in a cell (anti-
body-receptor targeting, activation of mono-NP clus-
ter  with  a  single  optical  wavelength),  the  rainbow 
PNB mechanism introduces several specific features: 
1. Nanobubble source: clusters of different NPs, 
rather than clusters of NPs of one type. This feature 
decreases  the  bubble  generation  threshold  fluence 
below the threshold level for mono-NP clusters. 
2.  Excitation  optical  wavelength  and  fluence: 
several simultaneous pulses at the wavelengths that 
match the plasmon resonances of the corresponding 
NPs in the cluster. This feature also reduces the flu-
ence  of  each  laser  pulse  below  the  threshold  for  a 
nanobubble  generated  through  a  “single  pulse  – 
mono-NP” mechanism. 
3. Independent control and tuning of the fluence: 
each excitation laser pulse provides maximal flexibil-
ity in manipulating the lifetime (i.e. size) of the rain-
bow PNB in a wide range of cluster size and compo-
sition, thus circumventing the problem of the hetero-
geneous formation and content of NP clusters in cells. 
All three above features are unique to rainbow 
PNBs and can be especially useful during in vivo ap-
plications where the heterogeneity of NP clustering 
and  optical  propagation  and  scattering  create  chal-
lenges both for nano- and for optical technologies. It 
should be noted that a rainbow PNB depends much 
less upon the variations of its NP content (this could 
be  caused  by  the  heterogeneous  interaction  and  in-
ternalization of gold NPs by the cell). This result, to-
gether with the tunable and multifunctional proper-
ties of PNBs in vitro and in vivo [34,40,50] that support 
diagnosis,  therapy  and  theranostics  (diagnosis  and 
treatment  united  in  one  procedure)  at  the  cellular 
level  and  with  single  cell  selectivity,  justify  the  de-
velopment  of  PNB  theranostic  technologies  despite 
the general limitations mentioned above.  
PNB theranostics in clinic  
 Rainbow nanobubbles offer the ability to target 
specific  pathology  at  cell  level  based  on  their 
theranostic  functions.  This  includes  their  ability  to 
generate bright optical probes at low fluence indicat-
ing they will provide an excellent imaging and guid-
ing tool in addition to their therapeutic applications. 
The application of PNB theranostics for focal prostate 
cancer treatment requires that the technology that can 
support PNB generation and detection in vitro be ex-
tended to  in vivo conditions. The goal is to achieve 
high cell level selectivity of tumor cell detection and 
ablation, with minimal harm to nearby vital tissues 
such as urethra and nerve. Fiber optical technology 
can provide local delivery and guidance of PNB based 
treatment  while  minimizing  the  negative  effects  of 
optical scattering of the tissue. We envision a clinical 
solution  for  PNB  theranostics  of  cancers  and  other 
pathologies through a fiber optical system (Figure 9). 
This  system  (Figure  9A)  will  support  the  essential 
features  of  PNBs  and  rainbow  bubbles  specifically 
including  simultaneous  delivery  of  several  pump 
pulses  of  specific  dynamically  variable  fluence  and 
wavelength,  continuous  probe  laser  radiation  and 
delivery of the suspension with NPs and, if necessary, 
of  optically  transparent  buffer  fluid.  The  radius  of 
propagation  of  near-infrared  laser  radiation  in  soft 
and tumor tissue (determined as a length that attenu-
ates the laser fluence by 63% relative to the fluence 
level near the fiber tip) was reported to be in the range 
of 5-8 mm [60-67]. This will be realized with a system 
based  on  a  rotating  and  sliding  fiber  probe  that  is 
guided though the needle and can be shifted in and 
out for approximately 10 mm. By rotating and sliding 
the fiber tip (Figure 9B) with side illumination (similar 
solutions  were  already  realized  for  laser  surgery 
[68-71])  we  will  generate  and  detect  the  PNBs  in  a 
cylindrical volume with a diameter of 10 mm and a 
height of 10 mm (Figure 9B). The diameter of the tip in 
clinical design can be minimized to 0.5-1.0 mm in or-
der to allow its minimally invasive penetration (up to 
10 mm) into the tissue. This fiber tip will be used for 
several functions: 
1.  PNB  generation:  several  pulses  of  different 
wavelengths  (preferably  in  NIR  region,  shown  in 
green in Figure 9) will be delivered through the side 
of the rotating fiber. The effective radius of laser pulse 
propagation also will be determined by the PNB gen-
eration thresholds for normal and prostate cancer cells Theranostics 2011, 1 
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(Figure  9B).  By  increasing  the  difference  between 
these  two  thresholds,  we  will  increase  the  effective 
radius of PNB treatment by allowing a high (though 
still safe) level of laser pulse fluence at the fiber tip 
exit  (Figure  9B).  According  to  ANSI  standard,  the 
safety threshold for NIR radiation in tissues is 25-40 
mJ/cm2  [46].  The  PNB  generation  threshold  was 
found to be lower (less than 10 mJ/cm2 for the clusters 
of  gold  nanoshells  in  cells).  The  speed  of  the  PNB 
treatment can be estimated through pulse energy and 
frequency: the maximal surface to be scanned with the 
tip shown in Figure 9B can be estimated by 3 cm2. A 
single  pulse  may  irradiate  the  area  of  10-3  cm2  (re-
quired energy will be about 100 μJ per pulse). Com-
mercial lasers deliver a pulse frequency up to 104 Hz, 
which results in a treatment time of less than 1 second 
per 1 cm3 (or per 3 cm2). This time includes the PNB 
generation and guidance and characterizes the com-
plete  PNB  theranostic  procedure  for  a  single  fiber 
probe. A bigger volume can be treated with several 
fiber probes simultaneously applied to the different 
locations  (similar  to  the  strategy  used  in  brachy-
therapy  [72]).  The  PNB  treatment  times  are  much 
shorter  than  those  reported  for  brachytherapy  and 
prostatectomy (tens minutes). 
2. PNB guidance: a continuous low power laser 
beam will be directed through the fiber coaxially with 
the pump pulses (Figure 9). The radiation scattered by 
PNB will be collected by peripheral optical fibers and 
detected by a high-sensitive photodetector. Relatively 
high scattering by the tissue will provide a relatively 
permanent  background  signal,  while  the  PNB  will 
deliver a transient signal of a specific shape that can 
be recognized in its time and frequency domains that 
are very different from those of the background. The 
duration of the detected signal will be used to monitor 
the size of the PNB, and, hence, will allow the guided 
destruction of the cells. This procedure will provide a 
real-time detection of PNBs, an estimation of their size 
and  a  dynamic  adjustment  of  the  fluences  of  the 
pump laser pulses while scanning the sample in order 
to adjust the diameter of PNBs to specific tissues or 
tumors. 
3. NP delivery: the same needle-fiber system can 
be used for advanced injection of gold NP conjugates.  
The described system will use the following al-
gorithms: (1) single pulse guided treatment: the pulse 
fluence will be automatically maintained to provide 
the PNB lifetime (size) above the cell ablation thresh-
old. Each detected PNB-specific signal of such dura-
tion will be counted as a confirmation of PC cell de-
struction;  (2)  theranostic  dual-pulse  treatment:  the 
first pulse will be close to the PNB generation thresh-
old  to  generate  small  non-invasive  PNBs;  upon  de-
tecting such signals the system will increase the en-
ergy to the ablative level and will generate the second 
pulse in the same direction to expose the same area or 
volume and to detect ablative PNBs. In the case of the 
absence of PNB-specific signals, the system will con-
tinue the scan at the minimal fluence level until it de-
tects the next target. 
 
 
 
Figure 9. Fiber optic PNB system for treatment of mulitfocal cancers such as prostate. A: general scheme that shows fiber 
optical probe connected through the fiber bundle to photodetector, through the multimode fiber to the pump and probe 
lasers, and through the capillaries to the syringe pump with the NPs and optical buffer fluid. B: scheme of the operation of 
fiber optic probe in tissue, volume scan is provided by sliding and rotating the probe in the guiding needle. C: the green line 
shows the attenuation of optical fluence in scattering tissue relative to the PNB thresholds for normal and prostate cancer 
(PC) cells, the difference between these thresholds determines an effective radius of PNB-based selective ablation of 
prostate cancer cells. 
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Conclusions 
We conclude that the suggested method of cell 
theranostics with “rainbow plasmonic nanobubbles” 
demonstrates  the  following  advantages  over  other 
methods of photothermal excitation of plasmonic NPs 
and PNBs: 
1. The synergistic excitation of several plasmon 
resonances  in  the  clusters  of  gold  (plasmonic)  NPs 
significantly improves the efficacy of the generation of 
plasmonic nanobubbles and is referred to as “rainbow 
plasmonic nanobubbles”. 
2. Rainbow plasmonic nanobubbles can be gen-
erated under reduced fluences of the excitation laser 
pulses that are below the PNB generation threshold 
for single NPs and for clusters consisting of only one 
type of NPs. 
3. The mechanism of rainbow plasmonic nano-
bubbles significantly improves the selectivity of bub-
ble generation in specific target cancer cells compared 
to  non-specific  stromal  (non-cancer)  cells  and  can 
therefore provide the cell level selectivity needed for 
diagnosis and therapy. 
4. Rainbow plasmonic nanobubbles are less sen-
sitive  to  the  NP  cluster  content  than  the  plasmonic 
nanobubbles  generated  around  mono-NP  clusters 
whose content can vary in cells due to the heteroge-
neous nature of NP uptake by living cells. 
5. PNBs demonstrate the tunability of their func-
tion in individual cells, thus performing the diagnosis 
and guided treatment that can be united into a single 
connected theranostic procedure. 
As a result rainbow plasmonic nanobubbles can 
be considered as a novel platform for developing cell 
level diagnostic, therapeutic and theranostic solutions 
for treating various pathologies such as prostate can-
cer. 
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